Back

The LRRK2 p.A419V variant associates with risk of Parkinson disease in the East Asian population and an evaluation on age of onset

Lim, K. S.; Perinan, M. T.; Chew, E. G. Y.; Lee, P. S.; Akcimen, F.; Lim, J. L.; Koretsky, M. J.; Funayama, M.; Yoshino, H.; Hattori, N.; Kaiyrzhanov, R.; Houlden, H.; Isayan, M.; Tay, Y. W.; Toh, T. S.; Lit, L.-C.; Khairul Anuar, A. N.; Ding, H. X.; Screven, L.; Mohamed Ibrahim, N.; Lin, C.-H.; Kim, H.-J.; Lee, J.-Y.; Chung, S. J.; Foo, J. N.; Tan, E.-K.; Lim, S.-Y.; Tan, A. H.; Bandres Ciga, S.; Ahmad-Annuar, A.; Global Parkinson's Genetics Program (GP2),

2025-09-02 genetic and genomic medicine
10.1101/2025.08.28.25333987 medRxiv
Show abstract

Common and rare variants in LRRK2 influence Parkinsons disease (PD) risk across diverse populations. We investigated the p.A419V variant across multiple ancestry cohorts comprising over 200,000 individuals. In cases of East Asian ancestry, the variant was significantly associated with increased risk (OR = 2.9; 95% CI: 1.66-5.10; p = 0.0002), It lies on rare EAS haplotypes, and was not in linkage disequilibrium with other LRRK2 coding variants. Although not significant, meta-analysis of age of onset in EAS cases show a suggestive trend ({beta} = -0.89 years; SE = 1.01; p = 0.380). LRRK2 protein modelling prediction indicated that binding sites for RAB8A, RAB10, RAB29 were in close proximity to the p.A419V variant within the ARM domain. Together, these findings confirm the p.A419V as a significant PD risk factor in EAS populations, as well as highlight disease-relevant variants in the ARM domain and the link with LRRK2-RAB signaling pathway.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.